Media advisory - NHL Alumni Association, NEEKA Healthcare Canada and Canopy Growth Team Up for a new Research Initiative

TORONTO and SMITHS FALLS, ON , March 1, 2019 /CNW/ - We would like to invite you to join us as NEEKA Healthcare Canada and Canopy Growth (WEED.TO) (CGC) unveil a transformative clinical research initiative in partnership with the NHL Alumni Association, a passionate advocate for improving the health and quality of life for all former NHL players.

There will be a press conference featuring Glenn Healy , Executive Director with the NHLAA and former NHL player, Dr. Amin Kassam from NEEKA Healthcare Canada, and from Canopy Growth, Dr. Mark Ware , Chief Medical Officer and Hilary Black , Chief Advocacy Officer. Additional former NHL players will also be in attendance.

Toronto, Ontario

Date: March 2, 2019

Time: Event begins at 2:45 p.m. EST . We recommend media arrive before 2:45 p.m. for set up.

Location: Artscape Sandbox, 301 Adelaide St. West, Toronto, ON

RSVP: If you're planning on attending, please RSVP with D'Arcy Mcdonell , [email protected]

About Canopy Growth Corporation
Canopy Growth is a world-leading diversified cannabis and hemp company, offering distinct brands and curated cannabis varieties in dried, oil and Softgel capsule forms. Canopy Growth offers medically approved vaporizers through the Company's subsidiary, Storz & Bickel GMbH & Co. KG. From product and process innovation to market execution, Canopy Growth is driven by a passion for leadership and a commitment to building a world-class cannabis company one product, site and country at a time. The Company has operations in over a dozen countries across five continents.

The Company is proudly dedicated to educating healthcare practitioners, conducting robust clinical research, and furthering the public's understanding of cannabis, and through its wholly owned subsidiary, Canopy Health Innovations ("Canopy Health"), has devoted millions of dollars toward cutting edge, commercializable research and IP development. Canopy Growth works with the Beckley Foundation and has launched Beckley Canopy Therapeutics to research and develop clinically validated cannabis-based medicines, with a strong focus on intellectual property protection. Canopy Growth acquired assets of leading hemp research company, ebbu, Inc. ("ebbu"). Intellectual Property ("IP") and R&D advancements achieved by ebbu's team apply directly to Canopy Growth's hemp and THC-rich cannabis genetic breeding program and its cannabis-infused beverage capabilities. Through partly owned subsidiary Canopy Rivers Corporation, the Company is providing resources and investment to new market entrants and building a portfolio of stable investments in the sector.

From our historic public listing on the Toronto Stock Exchange and New York Stock Exchange to our continued international expansion, pride in advancing shareholder value through leadership is engrained in all we do at Canopy Growth. Canopy Growth has established partnerships with leading sector names including cannabis icon Snoop Dogg, breeding legends DNA Genetics and Green House seeds, Battelle, the world's largest nonprofit research and development organization, and Fortune 500 alcohol leader Constellation Brands, to name but a few. Canopy Growth operates ten licensed cannabis production sites with over 4.3 million square feet of production capacity, including over 500,000 square feet of GMP certified production space. The Company operates Tweed retail stores in Newfoundland and Manitoba and has entered into supply agreements with every Canadian province and territory. For more information visit www.canopygrowth.com